Treatment of patients with genital endometriosis with synthetic sex hormones

Abstract

Histological examination of the endocervix in 80 patients with genital endometriosis, who took synthetic progestins and gestagens for therapeutic purposes, showed that pathological processes in the endocervix are not eliminated in parallel with the disappearance of pathological processes in the endometrium, but continue to recur. The occurrence of reserve cell hyperplasia with the transition to squamous metaplasia increases significantly as the duration of hormone therapy increases. This circumstance requires oncological vigilance.

Full Text

##article.viewOnOriginalSite##